Lynx1 Capital Management LP - Insider Trading & Ownership

Entity: Company
Location: 151 Calle De San Francisco, Suite 200 Pmb 1237, San Juan, Puerto Rico
Summary: The estimated value of insider holdings of Lynx1 Capital Management LP is at least $57.2M dollars as of December 16, 2024. Lynx1 Capital Management LP is the 10%+ Owner of TScan Therapeutics, Inc. and owns shares of TScan Therapeutics, Inc. (TCRX) stock worth about $51.2M. Lynx1 Capital Management LP is the 10%+ Owner of Passage BIO, Inc. and owns shares of Passage BIO, Inc. (PASG) stock worth about $5.96M.
All Insider Reports: All Insider Reports

Ownership of Lynx1 Capital Management LP

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TCRX	TScan Therapeutics, Inc.	10%+ Owner	$51.2M	+$36M	+238%	Dec 12, 2024
PASG	Passage BIO, Inc.	10%+ Owner	$5.96M	+$285K	+5.01%	Nov 25, 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.